A Florida company that sells products with cannabidiol has been warned for “unsubstantiated claims” that its products could be used to treat several ailments, including Parkinson’s and Alzheimer’s diseases.
The Food and Drug Administration and Federal Trade Commission issued the warning earlier this month in a joint letter to Rooted Apothecary LLC, in Naples, FL. The agency claims the company is illegally selling unapproved products containing CBD and has used its online store and social media sites to make unfounded claims about the products.
“We are working to protect Americans from companies marketing products with unsubstantiated claims that they prevent, diagnose, treat, or cure a number of diseases or conditions,” the agencies wrote. “As we examine potential regulatory pathways for the lawful marketing of cannabis products, protecting and promoting public health through sound, science-based decision-making remains our top priority.”
UK researchers are currently conducting a large-scale study to test if cannabinoids can effectively treat Parkinson’s psychosis symptoms.
Some providers, however, have been met with challenges regarding medical marijuana use with residents.
